Sarepta Therapeutics, Inc. (SRPT)

22.31 +0.76 (+3.53%) USD  |  NASDAQ  |  Dec 16, 15:03
More

Sarepta Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade